| | Patients characteristics | | Total (n = 25) | |
| | Age | (years, mean ± SD) | 63.3 ± 8.7 | | | Gender | (female / male) | 21 / 4 | | | Nutritional status (SGA) | n (%) | | | | | A - well-nourished | 5 (20) | | | | B - moderately malnourished | 12 (48) | | | | C - severely malnourished | 8 (32) | | | Weight | (kg, mean ± SD) | 61.4 ± 8.6 | | | BMI | (kg/m2, mean ± SD) | 20.8 ± 2.6 | | | Weight loss | in the last 3 months (yes / no) | 19 / 6 | | | Albumin | mean ± SD (g/dl) | 3.5 ± 0.4 | | | | max / min | 4.4 / 2.7 | | | | ≤ 3.5 g/dl, n (%) | 15 (60) | |
| | Prealbumin | mean ± SD (mg/dl) | 19.0 ±3.8 | | | | max / min | 25 /14 | | | | ≤ 20 mg/dl, n (%) | 17 (68) | |
| | CRP | mean ± SD, median (mg/L) | 75.8 ±56.2 | 54.4 | | | max / min | 194 /5.8 | | | | ≥10 mg/L, n (%) | 24 (96) | |
| | IL-6 | mean ± SD, median (pg/ml) | 26.0 ± 29.4 | 17.5 | | | max / min | 148.4 / 5.4 | | | | ≥ 18 pg/ml, n (%) | 11 (44) | |
| | IL-1β | mean ± SD, median (pg/ml) | 15.1 ± 24.3 | 9.7 | | | max / min | 100 / 0.61 | | | | ≥ 10 pg/ml, n (%) | 9 (36) | |
| | TNF-α | mean ± SD, median (pg/ml) | 36.2 ± 36.6 | 24.6 | | | max / min | 120 / 1.5 | | | | ≥ 24 pg/ml, n (%) | 13 (52) | |
| | LPL | mean ± SD, median (ng/ml) | 21.37 ± 24.2 | 11.6 | | | max / min | 105 / 3.8 | | | | > 12 ng/ml, n (%) | 11 (44) | |
| | Zinc | mean ± SD, median (mg/ml) | 54.7 ± 14.8 | 53.2 | | | max / min | 95.8 / 36.2 | | | | ≤ 70 mg/ml, n (%) | 22 (88) | |
| | 25-Hydroxycholecalciferol | mean ± SD, median (ng/ml) | 16.7 ± 6.6 | 15.2 | | | max / min | 34.8 / 7.3 | | | | ≤ 30 ng/ml, n (%) | 24 (96) | | | GSP n (%) | Both normal (CRP ≤10 mg/L, Albumin ≥3.5 g/dl) | 1 (4) | | | One abnormal (CRP ≤10 mg/L, Albumin <3.5 g/dl) | 4 (16) | | | Both abnormal (CRP >10 mg/L, Albumin <3.5 g/dl) | 20 (80) |
|
|
n: number, SGA: subjective global assessment, max/min = maximum/minimum, BMI: body mass index, CRP: C-reactive protein, IL6: interleukin 6, IL1-β: interleukin 1β, TNF-α: tumor necrosis factor alpha, LPL: lipoprotein lipase, GPS: Glasgow prognostic score.
|
